Biography and Research Information
OverviewAI-generated summary
Amanda Bradshaw's research focuses on the application of molecular biology techniques for the assessment of cancer characteristics. She has contributed to studies investigating genome-wide testing of archived ovarian and uterine carcinosarcoma tissue using FusionPlus Hi-C to determine homologous recombination deficiency (HRD) status. Bradshaw has co-authored publications with researchers such as Michael Birrer and Christopher Elms at the University of Arkansas for Medical Sciences, indicating collaborative efforts in this area of study.
Metrics
- Publications: 1
Selected Publications
-
Abstract 3970: Genome wide testing of archived ovarian and uterine carcinosarcoma FFPE tissue using FusionPlus Hi-C to determine HRD status (2026)
Collaboration Network
Top Collaborators
- Abstract 3970: Genome wide testing of archived ovarian and uterine carcinosarcoma FFPE tissue using FusionPlus Hi-C to determine HRD status
- Abstract 3970: Genome wide testing of archived ovarian and uterine carcinosarcoma FFPE tissue using FusionPlus Hi-C to determine HRD status
- Abstract 3970: Genome wide testing of archived ovarian and uterine carcinosarcoma FFPE tissue using FusionPlus Hi-C to determine HRD status
- Abstract 3970: Genome wide testing of archived ovarian and uterine carcinosarcoma FFPE tissue using FusionPlus Hi-C to determine HRD status
- Abstract 3970: Genome wide testing of archived ovarian and uterine carcinosarcoma FFPE tissue using FusionPlus Hi-C to determine HRD status
- Abstract 3970: Genome wide testing of archived ovarian and uterine carcinosarcoma FFPE tissue using FusionPlus Hi-C to determine HRD status
Similar Researchers
Based on overlapping research topics